The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder

Louis S. Matza, Anne M. Rentz, Kristina Secnik, Andrine R. Swensen, Dennis A. Revicki, David Michelson, Thomas Spencer, Jeffrey H. Newcorn, Christopher J Kratochvil

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Clinical research on attention-deficit hyperactivity disorder (ADHD) has begun to integrate measures of health-related quality of life (HRQL) as part of the overall assessment of treatment outcomes. This study examines the association between HRQL and measures of clinical symptoms of ADHD. Data were gathered from 297 children and adolescents in an 8-week, randomized, double-blind, placebo-controlled, clinical trial of atomoxetine treatment for ADHD. HRQL was assessed with the Child Health Questionnaire 50-item Parent Form. ADHD symptoms were assessed with the ADHD Rating Scale-IV; Parent Version and Clinical Global Impressions-ADHD-Severity. Associations between HRQL and clinical symptoms were assessed with correlations, analyses of variance with post hoc comparisons, and t tests. The Child Health Questionnaire 50-item Parent Form scales assessing psychosocial domains of HRQL were significantly negatively correlated with clinical measures. Improvement in clinical symptoms was associated with corresponding improvement in psychosocial aspects of HRQL. The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment.

Original languageEnglish (US)
Pages (from-to)166-174
Number of pages9
JournalJournal of Developmental and Behavioral Pediatrics
Volume25
Issue number3
DOIs
StatePublished - Jun 1 2004

Fingerprint

Attention Deficit Disorder with Hyperactivity
Quality of Life
Controlled Clinical Trials
Analysis of Variance
Placebos
Clinical Trials
Therapeutics
Research

Keywords

  • Attention-deficit hyperactivity disorder
  • Clinical trial
  • Health-related quality of life
  • Symptoms

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. / Matza, Louis S.; Rentz, Anne M.; Secnik, Kristina; Swensen, Andrine R.; Revicki, Dennis A.; Michelson, David; Spencer, Thomas; Newcorn, Jeffrey H.; Kratochvil, Christopher J.

In: Journal of Developmental and Behavioral Pediatrics, Vol. 25, No. 3, 01.06.2004, p. 166-174.

Research output: Contribution to journalArticle

Matza, Louis S. ; Rentz, Anne M. ; Secnik, Kristina ; Swensen, Andrine R. ; Revicki, Dennis A. ; Michelson, David ; Spencer, Thomas ; Newcorn, Jeffrey H. ; Kratochvil, Christopher J. / The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. In: Journal of Developmental and Behavioral Pediatrics. 2004 ; Vol. 25, No. 3. pp. 166-174.
@article{99505bae85e545a886a8ef8c05303722,
title = "The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder",
abstract = "Clinical research on attention-deficit hyperactivity disorder (ADHD) has begun to integrate measures of health-related quality of life (HRQL) as part of the overall assessment of treatment outcomes. This study examines the association between HRQL and measures of clinical symptoms of ADHD. Data were gathered from 297 children and adolescents in an 8-week, randomized, double-blind, placebo-controlled, clinical trial of atomoxetine treatment for ADHD. HRQL was assessed with the Child Health Questionnaire 50-item Parent Form. ADHD symptoms were assessed with the ADHD Rating Scale-IV; Parent Version and Clinical Global Impressions-ADHD-Severity. Associations between HRQL and clinical symptoms were assessed with correlations, analyses of variance with post hoc comparisons, and t tests. The Child Health Questionnaire 50-item Parent Form scales assessing psychosocial domains of HRQL were significantly negatively correlated with clinical measures. Improvement in clinical symptoms was associated with corresponding improvement in psychosocial aspects of HRQL. The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment.",
keywords = "Attention-deficit hyperactivity disorder, Clinical trial, Health-related quality of life, Symptoms",
author = "Matza, {Louis S.} and Rentz, {Anne M.} and Kristina Secnik and Swensen, {Andrine R.} and Revicki, {Dennis A.} and David Michelson and Thomas Spencer and Newcorn, {Jeffrey H.} and Kratochvil, {Christopher J}",
year = "2004",
month = "6",
day = "1",
doi = "10.1097/00004703-200406000-00005",
language = "English (US)",
volume = "25",
pages = "166--174",
journal = "Journal of Developmental and Behavioral Pediatrics",
issn = "0196-206X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder

AU - Matza, Louis S.

AU - Rentz, Anne M.

AU - Secnik, Kristina

AU - Swensen, Andrine R.

AU - Revicki, Dennis A.

AU - Michelson, David

AU - Spencer, Thomas

AU - Newcorn, Jeffrey H.

AU - Kratochvil, Christopher J

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Clinical research on attention-deficit hyperactivity disorder (ADHD) has begun to integrate measures of health-related quality of life (HRQL) as part of the overall assessment of treatment outcomes. This study examines the association between HRQL and measures of clinical symptoms of ADHD. Data were gathered from 297 children and adolescents in an 8-week, randomized, double-blind, placebo-controlled, clinical trial of atomoxetine treatment for ADHD. HRQL was assessed with the Child Health Questionnaire 50-item Parent Form. ADHD symptoms were assessed with the ADHD Rating Scale-IV; Parent Version and Clinical Global Impressions-ADHD-Severity. Associations between HRQL and clinical symptoms were assessed with correlations, analyses of variance with post hoc comparisons, and t tests. The Child Health Questionnaire 50-item Parent Form scales assessing psychosocial domains of HRQL were significantly negatively correlated with clinical measures. Improvement in clinical symptoms was associated with corresponding improvement in psychosocial aspects of HRQL. The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment.

AB - Clinical research on attention-deficit hyperactivity disorder (ADHD) has begun to integrate measures of health-related quality of life (HRQL) as part of the overall assessment of treatment outcomes. This study examines the association between HRQL and measures of clinical symptoms of ADHD. Data were gathered from 297 children and adolescents in an 8-week, randomized, double-blind, placebo-controlled, clinical trial of atomoxetine treatment for ADHD. HRQL was assessed with the Child Health Questionnaire 50-item Parent Form. ADHD symptoms were assessed with the ADHD Rating Scale-IV; Parent Version and Clinical Global Impressions-ADHD-Severity. Associations between HRQL and clinical symptoms were assessed with correlations, analyses of variance with post hoc comparisons, and t tests. The Child Health Questionnaire 50-item Parent Form scales assessing psychosocial domains of HRQL were significantly negatively correlated with clinical measures. Improvement in clinical symptoms was associated with corresponding improvement in psychosocial aspects of HRQL. The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment.

KW - Attention-deficit hyperactivity disorder

KW - Clinical trial

KW - Health-related quality of life

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=3242691681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242691681&partnerID=8YFLogxK

U2 - 10.1097/00004703-200406000-00005

DO - 10.1097/00004703-200406000-00005

M3 - Article

C2 - 15194901

AN - SCOPUS:3242691681

VL - 25

SP - 166

EP - 174

JO - Journal of Developmental and Behavioral Pediatrics

JF - Journal of Developmental and Behavioral Pediatrics

SN - 0196-206X

IS - 3

ER -